Tp117. Tp117 Covid-19 Pathophysiology and Modelling 2021
DOI: 10.1164/ajrccm-conference.2021.203.1_meetingabstracts.a4456
|View full text |Cite
|
Sign up to set email alerts
|

Post-Acute Respiratory Distress Syndrome Pulmonary Fibrosis and Pulmonary Artery Hypertension in Patients Affected by Severe COVID19

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2021
2021
2021
2021

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 0 publications
0
1
0
Order By: Relevance
“…PAH in ARDS did not increase mortality of ARDS, which was 36.6% for both groups [ 21 ]. PAH after recovery from ARDS was also reported in 60% of survivors with SARS-CoV-2 [ 22 ]. Increased circulating endothelin 1 (ET-1) levels and local deposition of hyaluronan/hyaluronic acid (HYA) in the lung parenchyma are indicators for PAH [ 23 ].…”
Section: Lung Changes In Ardsmentioning
confidence: 94%
“…PAH in ARDS did not increase mortality of ARDS, which was 36.6% for both groups [ 21 ]. PAH after recovery from ARDS was also reported in 60% of survivors with SARS-CoV-2 [ 22 ]. Increased circulating endothelin 1 (ET-1) levels and local deposition of hyaluronan/hyaluronic acid (HYA) in the lung parenchyma are indicators for PAH [ 23 ].…”
Section: Lung Changes In Ardsmentioning
confidence: 94%